noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Tekedia Capital LLC

China’s AI Chipmakers Reportedly Raise Prices as HBM Shortage Drives Up[...]
Tekedia Capital LLC

Oracle Raises 2027 Outlook, Shares Jump 7% as AI Cloud Boom Drives[...]
Tekedia Capital LLC

Nigerian Entrepreneurs Increasingly Like Hardware after Terra[...]

Healthcare

Immunic Inc.

09/11/2026 | Press release | Distributed by Public on 09/11/2026 15:25

Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

Resignation of Director

On September 10, 2026, Dr. Duane Nash resigned as a member of the Board of Directors (the "Board") of Immunic, Inc., a Delaware corporation (the "Company"). Dr. Nash's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies, or practices. The Board and the Company are deeply grateful for Dr. Nash's service, dedication, and contributions to the Company.

In connection with Dr. Nash's resignation, by resolution of the Board, the size of the Board was reduced from ten members to nine members.

Immunic Inc. published this content on September 11, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on September 11, 2026 at 21:25 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]